CLERICI, MARIO SALVATORE
CLERICI, MARIO SALVATORE
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
P2X7 receptors and multiple sclerosis: A potential biomarker and therapeutic target?
2026 C. Agliardi, F.R. Guerini, M. Clerici
Immune subversion by Leishmania infantum parasites suppresses NLRP3-driven inflammatory responses in amyloid-β-activated microglia
2025 E. Calvo Alvarez, C. Sfogliarini, F. La Rosa, M. Saresella, M. Dolci, E. Vegeto, D. Taramelli, N. Basilico, M. Clerici
Hidradenitis suppurativa, from basic science to surgery and a new era of tailored targeted therapy: An expert opinion paper
2025 A.V. Marzano, M. Bartoletti, V. Bettoli, L. Bianchi, A. Chiricozzi, M. Clerici, P. Dapavo, V. Dini, C. Foti, C. Magnoni, M. Megna, G. Micali, E. Molinelli, F. Prignano
Connecting the dots: Mitochondrial transfer in immunity, inflammation, and cancer
2025 V. Artusa, L. De Luca, M. Clerici, D. Trabattoni
Effects of microplastics on the immune system: How much should we worry?
2025 C. Vanetti, M. Broggiato, S. Pezzana, M. Clerici, C. Fenizia
Experimental Models to Investigate Viral and Cellular Dynamics in Respiratory Viral Co-Infections
2025 O. Yazici, C. Vanetti, M. Clerici, M. Biasin
Impact of Endoplasmic Reticulum Aminopeptidases 1 (ERAP1) and 2 (ERAP2) on Neutrophil Cellular Functions
2025 I. Saulle, F. Limanaqi, M. Garziano, M.L. Murno, V. Artusa, S. Strizzi, M. Giovarelli, C. Schulte, J. Aiello, M. Clerici, C. Vanetti, M. Biasin
Unveiling the impact of ERAP1 and ERAP2 on migration, angiogenesis and ER stress response
2025 I. Saulle, A.V. Vitalyos, D. D'Agate, M. Clerici, M. Biasin
Short‐lived neutralizing activity against SARS‐CoV‐2 in newborns of immunized mothers
2025 M. Stracuzzi, C. Vanetti, M. Garziano, M. Micheloni, M.L. Murno, G.V. Zuccotti, M. Clerici, V. Giacomet, D. Trabattoni
iPSC-derived human cortical organoids display profound alterations of cellular homeostasis following SARS-CoV-2 infection and Spike protein exposure
2025 G. Cappelletti, L. Brambilla, S. Strizzi, F. Limanaqi, V. Melzi, M. Rizzuti, M. Nizzardo, I. Saulle, D. Trabattoni, S. Corti, M. Clerici, M. Biasin
Effects of the VIVIFRAIL Exercise Protocol on Circulatory and Intracellular Peripheral Mediators Bridging Mitochondrial Dynamics and Inflammation in Robust and Frail Older People
2025 F. Limanaqi, E. Ferri, P. Ogno, F.R. Guerini, G.A. Mihali, T. Lucchi, M. Clerici, C. Fenoglio, L. D'Andrea, E. Marcello, M. Biasin, B. Arosio
Extracorporeal photopheresis as induction therapy in lung transplantation for cystic fibrosis: a pilot randomized trial
2025 I. Righi, C. Fenizia, D. Trabattoni, M. Nosotti, G. Grisorio, C. Vanetti, S. Di Tella, C. Mocellin, N. Fantini, D. Prati, L.C. Morlacchi, V. Rossetti, F. Blasi, M. Clerici, L.P. Rosso
Immunopathology of lung transplantation: from infection to rejection and vice versa
2024 I. Righi, I. Barone, L. Rosso, L.C. Morlacchi, V. Rossetti, G. Caffarena, F. Limanaqi, A. Palleschi, M. Clerici, D. Trabattoni
Impact of HLA allele-KIR partners on sexually transmitted HIV-1 infection
2024 C. Serrano-Rísquez, O. MOHAMED ALY, N. Rallón, J.M. Benito, A. Gómez-Vidal, F.J. Márquez, M. Alján, A. Rivero-Juárez, I. Pérez-Valero, A. Rivero, F. Sinangil, I. Saulle, M. Biasin, M. Clerici, D. Forthal, M.E. Saéz, A. Caruz
Humoral and cell-mediated immune responses in HIV-vertically infected young patients after three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine
2024 C. Vanetti, M. Stracuzzi, E. Crivellaro, F. Ciciliano, M. Garziano, C. Fenizia, M. Biasin, V. Rubinacci, A. Amendola, E. Tanzi, G.V. Zuccotti, M. Clerici, V. Giacomet, D. Trabattoni
New insights in non-invasive markers for rejection in lung transplanted patients
2024 I. Righi, D. Trabattoni, V. Vaira, A. Palleschi, A. Storaci, N. Manosur, C. Fenizia, C. Vanetti, L. Morlacchi, S. Franzi, M. Nosotti, L. Rosso, M. Clerici
Extracellular Vesicles as Biomarkers for Parkinson's Disease: How Far from Clinical Translation?
2024 A. Gualerzi, S. Picciolini, M. Bedoni, F.R. Guerini, M. Clerici, C. Agliardi
Serum miR-34a-5p, miR-103a-3p, and miR-376a-3p as possible biomarkers of conversion from relapsing-remitting to secondary progressive multiple sclerosis
2024 S. Agostini, R. Mancuso, L.A. Citterio, D. Caputo, L. Oreni, R. Nuzzi, M.B. Pasanisi, M. Rovaris, M. Clerici
EBV and multiple sclerosis: expression of LMP2A in MS patients
2024 S. Agostini, R. Mancuso, D. Caputo, M. Rovaris, M. Clerici
Increased concentrations of P2X7R in oligodendrocyte derived extracellular vesicles of Multiple sclerosis patients
2024 C. Agliardi, F.R. Guerini, M. Zanzottera, E. Bolognesi, D. Caputo, M. Rovaris, M. Clerici